{
  "meta": {
    "id": "test54",
    "title": "Nephrology-Ciliopathies__PKD__TTP",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 35-year-old patient is diagnosed with autosomal dominant polycystic kidney disease (ADPKD). Genetic testing reveals a mutation in the PKD1 gene. Which of the following mechanisms is most likely involved in the formation of renal cysts in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Decreased production of cyclic AMP (cAMP)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dysfunction of polycystin proteins on the primary cilium",
          "correct": true
        },
        {
          "label": "C",
          "text": "Overactivation of chloride and aquaporin channels",
          "correct": false
        },
        {
          "label": "D",
          "text": "Decreased proliferation of renal epithelial cells and increased fluid secretion",
          "correct": false
        }
      ],
      "correct_answer": "B. Dysfunction of polycystin proteins on the primary cilium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:691px\">\n<tbody>\n<tr>\n<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>ADPKD- Introduction and aetiology</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Formation of <strong>epithelial-lined cysts</strong> in kidneys affecting ~5% of tubules. Despite the small number, <span class=\"customMeta\" data-dictid=\"1405ad7b46169277718580acad7562\">cyst</span> growth disrupts surrounding tissue, leading to loss of <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> function.</li>\n<li>It is autosomal dominant with full <span class=\"customMeta\" data-dictid=\"cd2e83c3ad1692777195dad2ab75ec\">penetrance</span> but variable expressivity.</li>\n<li>Bilaterally enlarged kidneys with <span class=\"customMeta\" data-dictid=\"721937292f1692777185048f04ce29\">cortical</span> and <span class=\"customMeta\" data-dictid=\"0a36e18386169277719259641cf29b\">medullary</span> cysts are seen</li>\n<li>Key defects: <strong>(Option D ruled out)</strong>\n<ul>\n<li>Increased cell <span class=\"customMeta\" data-dictid=\"8eedb6cec61692777196a6a3b93d3f\">proliferation</span> and fluid secretion</li>\n<li>Decreased cell differentiation</li>\n<li>Abnormal <span class=\"customMeta\" data-dictid=\"ba366417791692777187229d34e597\">extracellular</span> matrix</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Genetic Heterogeneity</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li><strong>PKD1 mutations:</strong> ~85% of cases.</li>\n<li><strong>PKD2 mutations:</strong> ~15% (milder clinical presentation).</li>\n<li>Other genes: <strong>GANAB and DNAJB11 </strong>(rare cases, affecting polycystin-1 trafficking).</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Genetics</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Caused by mutations in PKD1 (polycystin-1) and PKD2 (polycystin-2).\n\t\t\t\t<ul>\n<li><strong>PKD1: large G-protein coupled receptor.</strong></li>\n<li><strong>PKD2: <span class=\"customMeta\" data-dictid=\"54de8b79a91692777183e608bc0dd4\">calcium</span> channel protein.</strong></li>\n</ul>\n</li>\n<li>Polycystin proteins interact on the <strong>primary cilium</strong>. <strong>(Option C)</strong>\n<ul>\n<li>Dysfunction leads to impaired <span class=\"customMeta\" data-dictid=\"54de8b79a91692777183e608bc0dd4\">calcium</span> signalling and <span class=\"customMeta\" data-dictid=\"1405ad7b46169277718580acad7562\">cyst</span> formation.</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Molecular Mechanisms</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Polycystin-1 and -2 Complex: Forms a receptor-channel complex involved in <span class=\"customMeta\" data-dictid=\"54de8b79a91692777183e608bc0dd4\">calcium</span> signalling and G-protein regulation.</li>\n<li>Affects processes like cell cycle, <span class=\"customMeta\" data-dictid=\"5d6a3738a016927771853497ecb24b\">cytoskeleton</span> organization, and cell migration.</li>\n<li>Disruption leads to <strong>abnormal <span class=\"customMeta\" data-dictid=\"54de8b79a91692777183e608bc0dd4\">calcium</span> signalling, and increased cAMP, </strong>promoting <span class=\"customMeta\" data-dictid=\"1405ad7b46169277718580acad7562\">cyst</span> growth<strong> via <span class=\"customMeta\" data-dictid=\"f7dbd0ab551692777184f9b1a73c6d\">chloride</span> and <span class=\"customMeta\" data-dictid=\"3f961706a01692777181011d842df8\">aquaporin</span> channels</strong>. <strong>(Option A and C ruled out)</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Cyst Formation</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li><strong>\"Second hit\" mutation</strong> in normal PKD1/ PKD2 <span class=\"customMeta\" data-dictid=\"88c5dcbf0a1692777181e199712f81\">allele</span> leads to <span class=\"customMeta\" data-dictid=\"1405ad7b46169277718580acad7562\">cyst</span> formation.</li>\n<li>Partial loss of function initiates <span class=\"customMeta\" data-dictid=\"1405ad7b46169277718580acad7562\">cyst</span> growth, accelerated by <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> injury or genetic/epigenetic changes.</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "fe1fc262"
    },
    {
      "text": "Which of the following is the earliest presentation of Autosomal dominant polycystic kidney disease (ADPKD)?",
      "options": [
        {
          "label": "A",
          "text": "Reduced GFR",
          "correct": false
        },
        {
          "label": "B",
          "text": "Urinary tract infection",
          "correct": false
        },
        {
          "label": "C",
          "text": "Renal stones",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypertension",
          "correct": true
        }
      ],
      "correct_answer": "D. Hypertension",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "eec237b7"
    },
    {
      "text": "Which of the following is least likely to be a case of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?",
      "options": [
        {
          "label": "A",
          "text": "2 cysts in one kidney of a 20-year-old",
          "correct": false
        },
        {
          "label": "B",
          "text": "2 cysts in each kidney of a 36-year-old",
          "correct": false
        },
        {
          "label": "C",
          "text": "4 cysts in each kidney of a 67-year-old",
          "correct": false
        },
        {
          "label": "D",
          "text": "2 cysts in one kidney of a 30-year-old",
          "correct": true
        }
      ],
      "correct_answer": "D. 2 cysts in one kidney of a 30-year-old",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:NaN\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Investigations</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Renal Ultrasonography.\n\t\t\t\t<ul>\n<li>Non-invasive, used for <span class=\"customMeta\" data-dictid=\"de809764741692777196fbafdae4e5\">presymptomatic</span> screening and donor evaluation.</li>\n<li>Limited sensitivity for PKD2 <span class=\"customMeta\" data-dictid=\"7a67bdf6f81692777193cfd480f228\">mutation</span> due to late-onset; may miss smaller cysts.</li>\n</ul>\n</li>\n<li>CT Scan\n\t\t\t\t<ul>\n<li>More sensitive than <span class=\"customMeta\" data-dictid=\"df077f2c3d16927772019f8223e58f\">ultrasound</span> for detecting smaller cysts.</li>\n</ul>\n</li>\n<li>T2-MRI (With/Without Contrast)\n\t\t\t\t<ul>\n<li>Detects cysts as small as 2\u20133 mm using <span class=\"customMeta\" data-dictid=\"e3767003061692777187b931c6a08f\">gadolinium</span> contrast.</li>\n<li>Minimal <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> <span class=\"customMeta\" data-dictid=\"d3323d4b271692777200122ea879e5\">toxicity</span> compared to CT contrast agents.</li>\n<li>Some cysts may remain undetected even with MRI.</li>\n</ul>\n</li>\n<li>Genetic Testing\n\t\t\t\t<ul>\n<li>Used in ambiguous cases or <span class=\"customMeta\" data-dictid=\"06123ff61a1692777182e19b790ebc\">atypical</span> presentations.</li>\n<li>Next-generation sequencing reduces costs and improves sensitivity.</li>\n<li>PKD1 gene testing is complex and expensive due to the presence of pseudogenes.</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Management</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Blood Pressure Control\n\t\t\t\t<ul>\n<li><strong>ACE inhibitors or ARBs</strong></li>\n</ul>\n</li>\n</ul>\n\t\t\t\u00a0\n\n\t\t\t<ul>\n<li>Antibiotic Treatment for <span class=\"customMeta\" data-dictid=\"1405ad7b46169277718580acad7562\">Cyst</span> Infections\n\t\t\t\t<ul>\n<li>Preferred Antibiotics: Lipid-soluble (trimethoprim-sulfamethoxazole, quinolones, chloramphenicol)</li>\n<li>Duration: 4\u20136 weeks</li>\n</ul>\n</li>\n</ul>\n\t\t\t\u00a0\n\n\t\t\t<ul>\n<li>Kidney Stone Management\n\t\t\t\t<ul>\n<li>Hydration</li>\n<li>Analgesics for pain relief</li>\n</ul>\n</li>\n</ul>\n\t\t\t\u00a0\n\n\t\t\t<ul>\n<li>Pain management:</li>\n</ul>\n<ul>\n<li>Analgesics</li>\n<li>Surgical <span class=\"customMeta\" data-dictid=\"1405ad7b46169277718580acad7562\">Cyst</span> Decompression</li>\n<li>Nerve Block</li>\n</ul>\n\t\t\t\u00a0\n\n\t\t\t<ul>\n<li>Dialysis and Transplantation:\n\t\t\t\t<ul>\n<li>Dialysis Options: Peritoneal <span class=\"customMeta\" data-dictid=\"5755720cc31692777186c957a0feb7\">dialysis</span> or hemodialysis</li>\n<li>Challenges with Peritoneal Dialysis: Limited <span class=\"customMeta\" data-dictid=\"b02812a466169277719090c2d27868\">intra-abdominal</span> space, increased risk of <span class=\"customMeta\" data-dictid=\"9cf1b2a8bc16927771899480554f5a\">hernia</span> and back pain</li>\n<li>Pre-transplant Nephrectomy: May be needed for large kidneys or <span class=\"customMeta\" data-dictid=\"c64e3a661b1692777197afc2ff7bca\">recurrent</span> infections to accommodate the graft</li>\n</ul>\n</li>\n</ul>\n\t\t\t\u00a0\n\n\t\t\t<ul>\n<li>Medications to Slow Disease Progression:\n\t\t\t\t<ul>\n<li>mTOR Inhibitors: Sirolimus, everolimus</li>\n<li>V2R Antagonists: Tolvaptan</li>\n<li>Somatostatin Analogues: Octreotide-LAR</li>\n<li>Combination Therapy: Enhances efficacy, reduces side effects</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "8e0f687b"
    },
    {
      "text": "A 2-day-old newborn presents with respiratory distress and low urine output. Prenatal ultrasound had shown enlarged, echogenic kidneys and reduced amniotic fluid levels. The family history reveals that the parents are related, but neither parent has any complaints. Which gene mutation is most likely responsible for this newborn\u2019s condition?",
      "options": [
        {
          "label": "A",
          "text": "PKHD1",
          "correct": true
        },
        {
          "label": "B",
          "text": "PKHD2",
          "correct": false
        },
        {
          "label": "C",
          "text": "PHD1",
          "correct": false
        },
        {
          "label": "D",
          "text": "PHD2",
          "correct": false
        }
      ],
      "correct_answer": "A. PKHD1",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Autosomal <span class=\"customMeta\" data-dictid=\"d54db2110416927771971e7c011a9f\">Recessive</span> <span class=\"customMeta\" data-dictid=\"ba336eb30516927771960f9d9bd85c\">Polycystic</span> <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">Kidney</span> Disease (ARPKD).</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Genetics</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li><strong>PKHD1</strong> gene <span class=\"customMeta\" data-dictid=\"7a67bdf6f81692777193cfd480f228\">mutation</span> on <span class=\"customMeta\" data-dictid=\"7157c1f59916927771846116d74646\">chromosome</span> 6p21.1\u20136p12.2</li>\n<li>Produces fibrocystin/polyductin (FPC)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Clinical Features</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Pre-neonatal and <span class=\"customMeta\" data-dictid=\"77493a5b781692777193df12530299\">Neonatal</span> period: <strong>Enlarged <span class=\"customMeta\" data-dictid=\"91b98150ea169277718629280d911c\">echogenic</span> kidneys, oligohydramnios, <span class=\"customMeta\" data-dictid=\"10e2dee19e1692777196673db90c23\">pulmonary</span> hypoplasia</strong></li>\n</ul>\n<ul>\n<li>Later stages: <strong>Systemic hypertension, progressive <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> failure, and liver involvement</strong></li>\n</ul>\n<ul>\n<li>Liver disease: <span class=\"customMeta\" data-dictid=\"488a4efe7d16927771840c9e29f164\">Congenital</span> <span class=\"customMeta\" data-dictid=\"3268e86ce01692777188f249c64d6e\">hepatic</span> <span class=\"customMeta\" data-dictid=\"21e2d5a70616927772021fcdec0ca9\">fibrosis</span> (CHF) and Caroli disease</li>\n<li>Portal <span class=\"customMeta\" data-dictid=\"45372f6c361692777189ff3209e642\">hypertension</span> with hepatosplenomegaly, <span class=\"customMeta\" data-dictid=\"d4607865bb1692777201a35341db81\">variceal</span> bleeding, and cholangitis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Management</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Neonatal care: <span class=\"customMeta\" data-dictid=\"901bf573f216927771905f0abedca2\">Intensive</span> care and <span class=\"customMeta\" data-dictid=\"263ee5444e1692777183a7e8e704da\">blood pressure</span> control</li>\n<li>Renal management: Dialysis, <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> transplantation</li>\n<li>Liver complications: May require liver <span class=\"customMeta\" data-dictid=\"ee9f07b0a81692777200e416e4e5d7\">transplantation</span> or <span class=\"customMeta\" data-dictid=\"e2218202be1692777196fa2a021f5e\">portosystemic</span> shunting for Caroli disease</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "f861a407"
    },
    {
      "text": "Which of the following is not a pathophysiology of Thrombotic thrombocytopenic purpura (TTP)?",
      "options": [
        {
          "label": "A",
          "text": "Reduced activity of ADAMTS14 enzyme",
          "correct": true
        },
        {
          "label": "B",
          "text": "Accumulation of ultra-large von Willebrand factor (VWF) multimers",
          "correct": false
        },
        {
          "label": "C",
          "text": "Platelet aggregation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Antibodies against ADAMTS13 enzyme",
          "correct": false
        }
      ],
      "correct_answer": "A. Reduced activity of ADAMTS14 enzyme",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "fb3f9e3d"
    },
    {
      "text": "A 35 Y/O male presents with fatigue, petechiae, and easy bruising. Over the past week, she has noticed increasing confusion and intermittent headaches. On examination, her blood pressure is normal, and she has no signs of active bleeding. Laboratory findings show the following: Haemoglobin: 7.5 g/dL Platelet count: 20,000/mm\u00b3 Blood smear: Schistocytes present LDH: Elevated Haptoglobin: Low Creatinine: 1.8 mg/dL Coagulation studies: Normal PT and aPTT What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "HELLP syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Disseminated Intravascular Coagulation (DIC)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Systemic Lupus Erythematosus (SLE)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Thrombotic Thrombocytopenic Purpura (TTP)",
          "correct": true
        }
      ],
      "correct_answer": "D. Thrombotic Thrombocytopenic Purpura (TTP)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "0b3cfd97"
    },
    {
      "text": "A 32-year-old female presents with fatigue, fever, and confusion. She also reports easy bruising and occasional nosebleeds. On examination, she has petechiae on her extremities and mild jaundice. What is the most effective initial treatment in addition to plasma exchange for this condition? Laboratory findings include: Hemoglobin: 7.0 g/dL Platelet count: 12,000/mm\u00b3 Blood smear: Schistocytes present LDH: Elevated Haptoglobin: Low Creatinine: 1.5 mg/dL Coagulation profile: Normal PT and aPTT",
      "options": [
        {
          "label": "A",
          "text": "Prednisolone",
          "correct": true
        },
        {
          "label": "B",
          "text": "Rituximab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vincristine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cyclophosphamide",
          "correct": false
        }
      ],
      "correct_answer": "A. Prednisolone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:334px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Features</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Points</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Platelet Count < 30,000/microlitre</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Reticulocyte count > 2.5%</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Indirect <span class=\"customMeta\" data-dictid=\"2d60c5a677169277718325a811dcf1\">bilirubin</span> > 2mg/dL</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>MCV < 90fL</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>INR < 1.5</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Creatinine < 2 mg/dL</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Undetectable Haptoglobin</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>1</p>\n</td>\n</tr>\n</tbody>\n</table>\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Plasma exchange (PEX) with high-dose <span class=\"customMeta\" data-dictid=\"a3e96d80e9169277718551158bbcd4\">corticosteroid</span> therapy.</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>The mainstay of treatment in TTP</strong></p>\n<ul>\n<li>Corticosteroids operate by decreasing the activity of the <span class=\"customMeta\" data-dictid=\"77c058b3b21692777197f5fd539d12\">reticuloendothelial</span> system as well as decreasing <span class=\"customMeta\" data-dictid=\"06e07ce7821692777182e8ffd9676f\">autoantibody</span> production.</li>\n<li>Both the ultra-large <span class=\"customMeta\" data-dictid=\"0327d20161169277720287847fa436\">VWF</span> multimers and the ADAMTS13 autoantibodies are effectively removed from <span class=\"customMeta\" data-dictid=\"337d16dac5169277718474b97f6e4a\">circulation</span> by <span class=\"customMeta\" data-dictid=\"a0e40688fa169277719572bdb48c92\">plasma</span> exchange therapy.</li>\n<li>The recommended volume of exchange is one <strong>estimated <span class=\"customMeta\" data-dictid=\"a0e40688fa169277719572bdb48c92\">plasma</span> volume (usually 40 mL/kg of body weight)</strong> with each treatment.</li>\n<li>The <strong>recommended dose for corticosteroids is 1 mg/kg per day of prednisolone.</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Rituximab</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>An anti-CD20 <span class=\"customMeta\" data-dictid=\"b2b82438d6169277719287eb450079\">monoclonal</span> <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> was found to help treat TTP <span class=\"customMeta\" data-dictid=\"3790c638ab16927771970a0a41d3ab\">refractory</span> to PEX. It targets B-lymphocytes and has a <strong>good response rate in <span class=\"customMeta\" data-dictid=\"3790c638ab16927771970a0a41d3ab\">refractory</span> and relapsed TTP.</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Caplacizumab</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>It has a high potential for TTP. It is a humanized <span class=\"customMeta\" data-dictid=\"b2b82438d6169277719287eb450079\">monoclonal</span> <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> fragment (a bivalent, variable-domain-only fragment) that attacks the A1 section of <span class=\"customMeta\" data-dictid=\"0327d20161169277720287847fa436\">VWF</span> and prevents <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> adhesion.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Other</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Splenectomy, vincristine, <span class=\"customMeta\" data-dictid=\"fa041055ec16927771858fe49c76d3\">cyclosporine</span> and cyclophosphamide.</strong></p>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "68e81d3e"
    },
    {
      "text": "A 28-year-old woman presents to the emergency department with fatigue, pallor and decreased urine output for the past three days. She reports a recent history of diarrhoea that started and has now resolved. Physical examination reveals pallor, mild jaundice, and petechiae on the lower limbs. Laboratory studies show haemoglobin of 7.8 g/dL, platelet count of 35,000/mm\u00b3, elevated serum creatinine of 2.5 mg/dL, and LDH of 950 U/L.A peripheral blood smear reveals schistocytes. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Hemolytic uremic syndrome (HUS)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Disseminated intravascular coagulation (DIC)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Systemic vasculitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Thrombotic thrombocytopenic purpura (TTP)",
          "correct": false
        }
      ],
      "correct_answer": "A. Hemolytic uremic syndrome (HUS)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Types</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Typical HUS/ D+HUS</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Shiga toxin-producing <span class=\"customMeta\" data-dictid=\"c2ea0d4bf01692777187d486aa6385\">Escherichia</span> <span class=\"customMeta\" data-dictid=\"cd0a7121a516927771846d8f5248bb\">coli</span> (STEC), called typical HUS, is the most common cause of HUS.</li>\n<li><strong>Escherichia <span class=\"customMeta\" data-dictid=\"cd0a7121a516927771846d8f5248bb\">coli</span> 0157:H7 (E <span class=\"customMeta\" data-dictid=\"cd0a7121a516927771846d8f5248bb\">coli</span> 0157:H7) </strong>has been <span class=\"customMeta\" data-dictid=\"8d0fca798b1692777191b6cd41880f\">linked</span> to typical HUS.</li>\n<li><strong>Typical HUS comprises 90% to 95% of HUS.</strong></li>\n<li>Commonly arises from consuming contaminated food or drink and through person-to-person contact.</li>\n<li>It has low <span class=\"customMeta\" data-dictid=\"9b7604d5461692777192546af7cabd\">morbidity</span> compared to <span class=\"customMeta\" data-dictid=\"06123ff61a1692777182e19b790ebc\">atypical</span> HUS.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Atypical HUS/</strong></p>\n<p><strong>D-HUS</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>The cause of aHUS is the <strong>abnormal <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> of the alternative <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> pathway. </strong></li>\n<li>The <span class=\"customMeta\" data-dictid=\"9f49574bce1692777181ca753a683c\">alternative <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> pathway</span> is activated with particular emphasis on regulatory Factor H, stabilises C3, and inactivates C3b.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Secondary HUS</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>HUS secondary to underlying conditions or infections, commonly presenting as aHUS with <span class=\"customMeta\" data-dictid=\"458e050fdc16927771809854c9fd53\">abnormal</span> <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> system activation.</li>\n<li>The most significant component of this category is HUS caused by <strong>Streptococcus pneumoniae.</strong></li>\n<li>Caused by Inherited vitamin B12 <span class=\"customMeta\" data-dictid=\"5b1a045f5f169277719210c0ac7a1e\">metabolism</span> disorder, HIV, <span class=\"customMeta\" data-dictid=\"c3817918b816927771902d2176d0c8\">influenza</span> virus and <span class=\"customMeta\" data-dictid=\"f8aaf091221692777191f73e810e94\">malignant</span> hypertension.</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "efa8c434"
    },
    {
      "text": "What is the first-line treatment for atypical hemolytic uremic syndrome (aHUS)?",
      "options": [
        {
          "label": "A",
          "text": "Eculizumab",
          "correct": true
        },
        {
          "label": "B",
          "text": "Ravulizumab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cyclophosphamide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rituximab",
          "correct": false
        }
      ],
      "correct_answer": "A. Eculizumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:625px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Types</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Typical HUS</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Management of typical HUS caused by <span class=\"customMeta\" data-dictid=\"1f21b98a111692777199de81e90bef\">STEC</span> is <strong>generally supportive.</strong></li>\n<li>Patients are often volume-depleted, and less volume <span class=\"customMeta\" data-dictid=\"d343b06c7f1692777197edaea107af\">resuscitation</span> has been <span class=\"customMeta\" data-dictid=\"8d0fca798b1692777191b6cd41880f\">linked</span> to an increased need for <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> replacement therapy.</li>\n<li><strong>Blood transfusions and <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> transfusions </strong>are provided to avoid thrombotic complications.</li>\n<li><strong>Antimotility agents and antibiotics are avoided in typical HUS</strong> caused by STEC, as they correlate with poorer outcomes, likely due to heightened <span class=\"customMeta\" data-dictid=\"f6cedefabe1692777198d050d24a4d\">Shiga toxin</span> exposure.</li>\n<li>If S dysenteriae or S <span class=\"customMeta\" data-dictid=\"1000989d33169277719652247cd559\">pneumonia</span> is present, early antibiotics are given to improve the outcomes.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Atypical HUS</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>The cornerstones of treatment for aHUS are <strong>first-line treatment with <span class=\"customMeta\" data-dictid=\"6a9b33e69916927771861bd0e99af4\">eculizumab</span> and second-line with <span class=\"customMeta\" data-dictid=\"a0e40688fa169277719572bdb48c92\">plasma</span> exchange.</strong></li>\n<li><strong>Eculizumab</strong> is a <span class=\"customMeta\" data-dictid=\"b566321fe8169277719716b1cf4df0\">recombinant</span> <span class=\"customMeta\" data-dictid=\"b2b82438d6169277719287eb450079\">monoclonal</span> <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> that targets the C5 component of <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> by preventing its cleavage.</li>\n<li><strong>Ravulizumab</strong> is a new C5 <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> that binds to C5 preventing <span class=\"customMeta\" data-dictid=\"db5610b3121692777184e0965a9fa4\">cleavage</span> and it has similar <span class=\"customMeta\" data-dictid=\"7f80be61231692777187391e91e867\">efficacy</span> to <span class=\"customMeta\" data-dictid=\"6a9b33e69916927771861bd0e99af4\">eculizumab</span> but with 4 times as long of a half-life.</li>\n<li><strong>Adverse effects of eculizumab</strong> are infection by <span class=\"customMeta\" data-dictid=\"e26ba9a1d41692777187d0ad03a8c1\">encapsulated</span> organisms such as S pneumoniae and <span class=\"customMeta\" data-dictid=\"e8810d5c6b169277718827849b05a3\">Haemophilus</span> influenzae, and all patients should be given appropriate vaccines and monitored.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Secondary HUS</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Depends on the treatment of the underlying condition.</li>\n<li><strong>Eculizumab</strong> has some <span class=\"customMeta\" data-dictid=\"7f80be61231692777187391e91e867\">efficacy</span> in treating <strong>pregnancy-related secondary HUS.</strong></li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "59706da4"
    },
    {
      "text": "A 40-year-old female came to OP with a fever, weakness of the right side of her body, and bleeding episodes while brushing. Preliminary investigations revealed S.Creatinine: 2 mg/dL (0.6-1.1 mg/dl) Platelet count: 20,000 cells/cu.mm (1,50,000-4,00,000 cells/cu.mm) Bleeding time: 10 mins (2-7 mins) PT: 15 sec (11.5-13.5 seconds) aPTT: 38 sec (21-35 seconds) Peripheral smear revealed the following  What is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Immune thrombocytopenic purpura",
          "correct": false
        },
        {
          "label": "B",
          "text": "IgA Vasculitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thrombotic thrombocytopenic purpura",
          "correct": true
        },
        {
          "label": "D",
          "text": "Disseminated intravascular coagulation",
          "correct": false
        }
      ],
      "correct_answer": "C. Thrombotic thrombocytopenic purpura",
      "question_images": [
        "https://image.prepladder.com/notes/B9uwq9gorD6ZWKPqP4Ym1744291447.png"
      ],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:617px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\u00a0</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>ITP</strong><strong> (Option A ruled out)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>TTP</strong><strong> (Option C)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>HSP </strong><strong>(Option A ruled out)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>DIC </strong><strong>(Option A ruled out)</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Age</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Child (5-15 y)</li>\n<li>Middle-aged females (20-40y)</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Middle-aged females >> males</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Children usually in the first decade</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>No specific age predominance</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Cause</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Autoimmune causes</li>\n<li>Associated with <span class=\"customMeta\" data-dictid=\"96ab11a06a16927771823151c8e471\">autoimmune</span> diseases - mainly SLE.</li>\n<li>Infections: HIV, Hep-C, H.pylori</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Deficiency/autoantibodies to ADAMTS-13</li>\n<li>ADAMTS-13 is responsible for cleaving vWF.</li>\n<li>Deficiency of ADAMTS-13 leads to \u2191 <span class=\"customMeta\" data-dictid=\"0327d20161169277720287847fa436\">vWF</span> levels.</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>IgA-mediated <span class=\"customMeta\" data-dictid=\"fcb3e0d7911692777201ffb9695dea\">Vasculitis</span> - blood vessels are affected, and platelets are spared</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Sepsis</li>\n<li>Trauma</li>\n<li>Malignancy (AML-M3)</li>\n<li>Obstetric: <span class=\"customMeta\" data-dictid=\"f5df620f42169277718051194dc6e4\">Abruptio</span> placenta, <span class=\"customMeta\" data-dictid=\"2c0fb943ce16927771815ddeb9824d\">amniotic</span> fluid embolism</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Clinical features</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Fever + thrombo- cytopenia</li>\n<li>Self-resolving in children</li>\n<li>May cause <span class=\"customMeta\" data-dictid=\"41e858bf2816927771836d46c619b9\">bleeding</span> manifestations in adults</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Fever + thrombo- cytopenia</li>\n<li>MAHA</li>\n<li>Stroke</li>\n<li>AKI/CKD</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Non thrombo- cytopenic Purpura</li>\n<li>Fever</li>\n<li>AKI (rarely)</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Low <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> counts with <span class=\"customMeta\" data-dictid=\"41e858bf2816927771836d46c619b9\">bleeding</span> manifestations + <span class=\"customMeta\" data-dictid=\"bf6247405e16927771891b6a068d36\">hypotensive</span> shock</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\u00a0</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\u00a0</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>C3 - Normal (N)</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Fibrinogen - N</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Fibrinogen - \u2193</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>BT</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>\u2191</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>N</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>\u2191</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>\u2191</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>PT</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>N</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>N</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>N/ minor \u2191</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>\u2191</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>aPTT</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>N</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>N</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>N/ minor \u2191</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>\u2191</p>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "65509300"
    },
    {
      "text": "Primary cilia of the kidney are present in all of the following except",
      "options": [
        {
          "label": "A",
          "text": "Principal cells of Collecting duct",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intercalated cells of Collecting duct",
          "correct": true
        },
        {
          "label": "C",
          "text": "Proximal convoluted tubule (PCT)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Distal convoluted tubule (DCT)",
          "correct": false
        }
      ],
      "correct_answer": "B. Intercalated cells of Collecting duct",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Introduction</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Specialized microtubule-based projections from the <span class=\"customMeta\" data-dictid=\"c6223a27fb169277718147405290e1\">apical</span> surface of epithelial cells of the kidney.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Functions</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Mainly responsible for <span class=\"customMeta\" data-dictid=\"28f5a05c8b1692777198471034364a\">signal transduction</span> by</p>\n<ul>\n<li><strong>Chemosensors: </strong>measures <span class=\"customMeta\" data-dictid=\"2e0552462e16927771871413861fb7\">electrolyte</span> traversing the tubule</li>\n<li><strong>Mechanosensors:</strong> measure the volume of <span class=\"customMeta\" data-dictid=\"e0c336554f16927772018d95c26ac1\">ultrafiltrate</span> passing through the kidney.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Locations</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Present in all epithelial cells of the kidney</p>\n<ul>\n<li>Proximal <span class=\"customMeta\" data-dictid=\"3ddb367f1c16927771854815522adf\">convoluted</span> <span class=\"customMeta\" data-dictid=\"4ba1c48e851692777201a91713191e\">tubule</span> (PCT) <strong>(Option C ruled out)</strong></li>\n<li>Distal <span class=\"customMeta\" data-dictid=\"3ddb367f1c16927771854815522adf\">convoluted</span> <span class=\"customMeta\" data-dictid=\"4ba1c48e851692777201a91713191e\">tubule</span> (DCT) <strong>(Option D ruled out)</strong></li>\n<li>Principal cells of Collecting <span class=\"customMeta\" data-dictid=\"6198b5f22b16927771867e4ef8108f\">duct</span> <strong>(Option A ruled out)</strong></li>\n</ul>\n<p><strong>EXCEPT: <span class=\"customMeta\" data-dictid=\"cfd35769b016927771901681bcc115\">Intercalated</span> cells of Collecting <span class=\"customMeta\" data-dictid=\"6198b5f22b16927771867e4ef8108f\">duct</span> & Loop of Henle</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Disorders</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Mutations in ciliary-associated proteins result in diseases together known as <strong>Ciliopathies</strong>. A few examples in kidneys are,</p>\n<ul>\n<li>Autosomal Dominant Variety of <span class=\"customMeta\" data-dictid=\"ba336eb30516927771960f9d9bd85c\">Polycystic</span> <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">Kidney</span> Disease <strong>(ADPKD)</strong></li>\n<li>Autosomal <span class=\"customMeta\" data-dictid=\"d54db2110416927771971e7c011a9f\">Recessive</span> <span class=\"customMeta\" data-dictid=\"ba336eb30516927771960f9d9bd85c\">Polycystic</span> <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">Kidney</span> Disease <strong>(ARPKD)</strong></li>\n<li><strong>Medullary <span class=\"customMeta\" data-dictid=\"1f8d123d5a16927771996d6f75145f\">Sponge</span> Kidney</strong> (MSK)</li>\n<li>Medullary <span class=\"customMeta\" data-dictid=\"38c41e122116927771859b63deb0ed\">Cystic</span> <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">Kidney</span> Disease (MCKD) / <strong>Autosomal Dominant <span class=\"customMeta\" data-dictid=\"11a108da951692777201ccf7220331\">Tubulointerstitial</span> <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">Kidney</span> Disease (ADTKD)</strong></li>\n</ul>\n<div style=\"text-align:center\">\n<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"Wheel depicting primary ciliopathies\" custommeta\"=\"\" data-author=\"Dewhurst, Rebecca & Molinari, Elisa & Sayer, John. (2023). Spheroids, organoids and kidneys-on-chips: how complex human cellular models have assisted in the study of <span class=\" data-dictid=\"4aa6035df41692777190b41d4a1583\"/>kidney disease and renal ciliopathies. Microfluidics and Nanofluidics. 27. 10.1007/s10404-023-02629-4. \" data-hash=\"8552\" data-license=\"CC BY 4.0\" data-source=\"https://www.researchgate.net/figure/Wheel-depicting-primary-ciliopathies-which-present-with-a-renal-phenotype-Other-common_fig3_368605929\" data-tags=\"\" src=\"https://image.prepladder.com/notes/2zunkKH9Um9R8hBDB8wl1744291660.png\" />\n\t\t\t<figcaption>{{caption_text}}</figcaption>\n</figure>\n</div>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "971fe879"
    },
    {
      "text": "A 50-year-old male presented with recurrent episodes of hematuria associated with loin pain for the past 6 months. He also gives a history of episodes of recurrent UTIs in his early childhood. IVP done showed the following.  What is the most likely composition of renal stones in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Calcium oxalate",
          "correct": true
        },
        {
          "label": "B",
          "text": "Struvite",
          "correct": false
        },
        {
          "label": "C",
          "text": "Uric acid",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cystine",
          "correct": false
        }
      ],
      "correct_answer": "A. Calcium oxalate",
      "question_images": [
        "https://image.prepladder.com/notes/KEgmnIUKeHWnX65FZfAy1744291789.png"
      ],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Description</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Cystic dilatations of <span class=\"customMeta\" data-dictid=\"16b76d1d1c1692777200240efcb0e2\">terminal</span> portions of collecting duct</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Clinical presentation</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Childhood: usually <span class=\"customMeta\" data-dictid=\"d1a9a79f701692777182066af09044\">asymptomatic</span> or may have episodes of <span class=\"customMeta\" data-dictid=\"c64e3a661b1692777197afc2ff7bca\">Recurrent</span> UTI</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Adult: 50-60 years</strong></p>\n<ul>\n<li>Nephrolithiasis: <strong>Calcium oxalate</strong> stone (most common) <strong>(Option A)</strong></li>\n<li>Recurrent hematuria</li>\n<li>Pyelonephritis: secondary to <span class=\"customMeta\" data-dictid=\"c64e3a661b1692777197afc2ff7bca\">recurrent</span> UTI</li>\n<li>Polyuria:<strong> <span class=\"customMeta\" data-dictid=\"359a8718a61692777185568ac80abb\">defect</span> in collecting <span class=\"customMeta\" data-dictid=\"6198b5f22b16927771867e4ef8108f\">duct</span> receptors</strong></li>\n<li>anaemia: <span class=\"customMeta\" data-dictid=\"ce12dc160c1692777195473ab2cc21\">Peritubular</span> cell damage \u2192 \u2193 <span class=\"customMeta\" data-dictid=\"ec50ec51401692777187009530441d\">Erythropoietin</span> levels</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Diagnosis</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li><strong>IVP: <span class=\"customMeta\" data-dictid=\"7619c1f37016927771836a9a61bc25\">Bouquet</span> of <span class=\"customMeta\" data-dictid=\"885830d4c216927772022cdb65cbf1\">flowers</span> (or) Paint brush appearance</strong></li>\n<li>USG: Associated <span class=\"customMeta\" data-dictid=\"0a36e18386169277719259641cf29b\">medullary</span> <span class=\"customMeta\" data-dictid=\"e0869bcc2d169277719336bc5b8a6d\">nephrocalcinosis</span> may be seen</li>\n<li>CT: NCCT/Helical CT - Best Investigation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Management</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Treatment of complications</li>\n<li>UTI prophylaxis</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "adbb6a11"
    },
    {
      "text": "A male patient was diagnosed with End Stage Renal Disease (ESRD) at the age of 30y. On evaluation, mutation analysis was positive for the UMOD (Uromodulin) gene. Which among the following is the least likely manifestation of this condition?",
      "options": [
        {
          "label": "A",
          "text": "Polyuria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bland urinary sediments",
          "correct": false
        },
        {
          "label": "C",
          "text": "Polycythemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Gout",
          "correct": false
        }
      ],
      "correct_answer": "C. Polycythemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Description</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Group of inherited <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> disorder characterised by Tubulo-interstitial <span class=\"customMeta\" data-dictid=\"b06dd1c5181692777193f14f3ed7d7\">nephropathy</span> and <span class=\"customMeta\" data-dictid=\"862b9b46641692777183ea602de834\">bland</span> <span class=\"customMeta\" data-dictid=\"0b72f5e96b16927772018dec8a87e2\">urinary</span> sediments.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Genes</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li><strong>UMOD</strong> (Uromodulin)</li>\n<li><strong>MUC-1</strong> (Mucin)</li>\n<li>Other genes: <span class=\"customMeta\" data-dictid=\"fe8bf9d7d7169277719780a365f7a4\">REN</span> (Renin), HNF1\u03b2 (Hepatocyte nuclear factor)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Inheritance</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Autosomal dominant pattern</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Manifestations/ Complications</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li><strong>Polyuria: </strong>Tubulointerstitial disorders have a non-oliguric presentation <strong>(Option A)</strong></li>\n<li><strong>anaemia: </strong>Peritubular cell damage \u2192 \u2193 <span class=\"customMeta\" data-dictid=\"ec50ec51401692777187009530441d\">Erythropoietin</span> levels <strong>(Option C)</strong></li>\n<li><strong>CKD/ESRD:</strong> Due to progressive <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> damage</li>\n<li><strong>Gout:</strong> usual presentation in adults, mainly in <strong>ADTKD-UMOD</strong> <strong>(Option D)</strong></li>\n<li>Hypovolemia: mainly seen in ADTKD-REN</li>\n<li>Liver damage: mainly seen in ADTKD-HNF1\u03b2</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Diagnosis</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Urine examination: <strong>Bland <span class=\"customMeta\" data-dictid=\"0b72f5e96b16927772018dec8a87e2\">urinary</span> sediments - most specific finding </strong>(RBC/WBC/Epithelial casts) <strong>(Option B)</strong></li>\n<li><strong>USG: Shrunken kidneys</strong></li>\n<li>Histopathology: <span class=\"customMeta\" data-dictid=\"98d387b7bd1692777201278b27be72\">Tubular</span> atrophy, <span class=\"customMeta\" data-dictid=\"11a108da951692777201ccf7220331\">tubulointerstitial</span> fibrosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Management</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Anti-gout drugs: <strong>Allopurinol and Febuxostat</strong> are mainly useful in <strong>ADTKD-UMOD.</strong></li>\n<li>Replenishment of body fluids & Supportive care</li>\n<li>Hemodialysis</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "e8f4d8c9"
    }
  ]
}